Vivos Therapeutics Confirms Nasdaq Listing Standard Compliance
Vivos Therapeutics, Inc. has received a letter from The Nasdaq Stock Market confirming its continued compliance with the stockholders' equity standard following a major equity transaction, averting immediate delisting risks.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed